{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:52:07Z","timestamp":1777560727664,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi del Piemonte Orientale Amedeo Avogrado"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The uncertainty on the management of small adrenal incidentalomas (AIs) still represents a challenge in real clinical practice. Considering the lack of knowledge on risk factors implicated in tumour enlargement, the aim of this study was to identify risk factors for morphological changes during follow-up of adrenal incidentalomas (AIs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively evaluated demographic, clinical, radiological and biochemical parameters of 153 AIs (2007\u20132021). Patients with histological diagnosis of metastases or pheochromocytoma were excluded. To detect risk factors for tumor enlargement, diseases associated with AIs were included if their prevalence was higher than 2%. Patients were divided into two groups (A: radiological stability; B: tumor enlargement defined as\u2009&gt;\u20095\u00a0mm\/year in the main diameter).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Group A: 89.5% and group B: 10.5%, mean follow-up 38.6\u2009\u00b1\u20096.9\u00a0months (range 6\u2013240). Tumor enlargement when occurred was within 36\u00a0months of follow-up. In group B high body weight (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.03), dehydroepiandrosterone sulfate (DHEAS) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and direct renin concentration (DRC) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.04) were higher than group A, while aldosterone levels were lower; moreover, considering comorbidities, glaucoma and dysglycemia (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01 for both) had higher prevalence in group B. Glaucoma and dysglycemia were independent predictors of enlargement. Patients affected by glaucoma, atrial fibrillation, dysglycemia had a lower dimensional change-free survival than non-affected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Glaucoma might be a novel risk factor for AI enlargement. If subtle undetectable cortisol hypersecretion has a role is a topic for further research.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-023-02154-9","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T07:05:49Z","timestamp":1689750349000},"page":"377-387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumor enlargement in adrenal incidentaloma is related to glaucoma: a new prognostic feature?"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0470-9343","authenticated-orcid":false,"given":"M.","family":"Caputo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Daffara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Romanisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Monti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zavattaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tricca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Siani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"De Cill\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Carriero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Marzullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Aimaretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Prodam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"issue":"4","key":"2154_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/BF03344099","volume":"29","author":"S Bovio","year":"2006","unstructured":"Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M (2006) Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29(4):298\u2013302. https:\/\/doi.org\/10.1007\/BF03344099","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2154_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3803\/EnM.2020.35.1.26","volume":"35","author":"G Reimondo","year":"2020","unstructured":"Reimondo G, Muller A, Ingargiola E, Puglisi S, Terzolo M (2020) Is follow-up of adrenal incidentalomas always mandatory? Endocrinol Metab (Seoul) 35(1):26\u201335. https:\/\/doi.org\/10.3803\/EnM.2020.35.1.26","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"2","key":"2154_CR3","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175(2):G1\u2013G34. https:\/\/doi.org\/10.1530\/EJE-16-0467","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2154_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1210\/jcem.85.2.6372","volume":"85","author":"F Mantero","year":"2000","unstructured":"Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Al\u00ec A, Giovagnetti M, Opocher G, Angeli A (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85(2):637\u201344. https:\/\/doi.org\/10.1210\/jcem.85.2.6372","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2154_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jviscsurg.2014.07.002","volume":"151","author":"F Menegaux","year":"2014","unstructured":"Menegaux F, Ch\u00e9reau N, Peix JL, Christou N, Lifante JC, Paladino NC, Sebag F, Ghander C, Tr\u00e9sallet C, Mathonnet M (2014) Management of adrenal incidentaloma. J Visc Surg 151(5):355\u2013364. https:\/\/doi.org\/10.1016\/j.jviscsurg.2014.07.002","journal-title":"J Visc Surg"},{"key":"2154_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1530\/EJE-17-0372","volume":"177","author":"AR Hong","year":"2017","unstructured":"Hong AR, Kim JH, Park KS, Kim KY, Lee JH, Kong SH, Lee SY, Shin CS, Kim SW, Kim SY (2017) Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice. Eur J Endocrinol 177:475\u2013483. https:\/\/doi.org\/10.1530\/EJE-17-0372","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2154_CR7","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","volume":"106","author":"I Bancos","year":"2021","unstructured":"Bancos I, Prete A (2021) Approach to the patient with adrenal incidentaloma. J Clin Endocrinol Metab 106(11):3331\u20133353. https:\/\/doi.org\/10.1210\/clinem\/dgab512","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2154_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1210\/jcem.84.2.5444","volume":"84","author":"L Barzon","year":"1999","unstructured":"Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M (1999) Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 84(2):520\u2013526. https:\/\/doi.org\/10.1210\/jcem.84.2.5444","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2154_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jc.2013-3527","volume":"99","author":"V Morelli","year":"2014","unstructured":"Morelli V, Reimondo G, Giordano R, Della Casa S, Policola C, Palmieri S, Salcuni AS, Dolci A, Mendola M, Arosio M, Ambrosi B, Scillitani A, Ghigo E, Beck-Peccoz P, Terzolo M, Chiodini I (2014) Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. J Clin Endocrinol Metab 99(3):827\u2013834. https:\/\/doi.org\/10.1210\/jc.2013-3527","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2154_CR10","doi-asserted-by":"publisher","first-page":"e3307","DOI":"10.1210\/clinem\/dgaa410","volume":"105","author":"S Singh","year":"2020","unstructured":"Singh S, Atkinson EJ, Achenbach SJ, LeBrasseur N, Bancos I (2020) Frailty in patients with mild autonomous cortisol secretion is higher than in patients with nonfunctioning adrenal tumors. J Clin Endocrinol Metab 105(9):e3307\u2013e3315. https:\/\/doi.org\/10.1210\/clinem\/dgaa410","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2154_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","volume":"2","author":"G Di Dalmazi","year":"2014","unstructured":"Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, Mosconi C, Golfieri R, Paccapelo A, Pagotto U, Pasquali R (2014) Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol 2(5):396\u2013405. https:\/\/doi.org\/10.1016\/S2213-8587(13)70211-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2154_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP.15.S1.1","volume":"15","author":"MA Zeiger","year":"2009","unstructured":"Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, Fishman E, Kharlip J, American Association of Clinical Endocrinologists; American Association of Endocrine Surgeons (2009) The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 15(1):1\u201320. https:\/\/doi.org\/10.4158\/EP.15.S1.1","journal-title":"Endocr Pract"},{"issue":"4","key":"2154_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5489\/cuaj.11135","volume":"5","author":"A Kapoor","year":"2011","unstructured":"Kapoor A, Morris T, Rebello R (2011) Guidelines for the management of the incidentally discovered adrenal mass. Can Urol Assoc J 5(4):241\u2013247. https:\/\/doi.org\/10.5489\/cuaj.11135","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"2154_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3803\/EnM.2017.32.2.200","volume":"32","author":"JM Lee","year":"2017","unstructured":"Lee JM, Kim MK, Ko SH, Koh JM, Kim BY, Kim SW, Kim SK, Kim HJ, Ryu OH, Park J, Lim JS, Kim SY, Shong YK, Yoo SJ, Korean Endocrine Society, Committee for Clinical Practice Guideline (2017) Clinical guidelines for the management of adrenal incidentaloma. Endocrinol Metab (Seoul) 32(2):200\u2013218. https:\/\/doi.org\/10.3803\/EnM.2017.32.2.200","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"6","key":"2154_CR15","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1530\/EJE-10-1147","volume":"164","author":"M Terzolo","year":"2011","unstructured":"Terzolo M, Stigliano A, Chiodini I, Loli P, Furlani L, Arnaldi G, Reimondo G, Pia A, Toscano V, Zini M, Borretta G, Papini E, Garofalo P, Allolio B, Dupas B, Mantero F, Tabarin A, Italian Association of Clinical Endocrinologists (2011) AME position statement on adrenal incidentaloma. Eur J Endocrinol 164(6):851\u2013870. https:\/\/doi.org\/10.1530\/EJE-10-1147","journal-title":"Eur J Endocrinol"},{"key":"2154_CR16","unstructured":"NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d). NIH Consens State Sci Statements. 2002 19: 1\u201325. PMID: 14768652"},{"issue":"6","key":"2154_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ando.2008.09.003","volume":"69","author":"A Tabarin","year":"2008","unstructured":"Tabarin A, Bardet S, Bertherat J, Dupas B, Chabre O, Hamoir E, Laurent F, Tenenbaum F, Cazalda M, Lefebvre H, Valli N, Rohmer V, French Society of Endocrinology Consensus (2008) Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus. Ann Endocrinol (Paris) 69(6):487\u2013500. https:\/\/doi.org\/10.1016\/j.ando.2008.09.003","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"2154_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.5603\/EP.a2016.0039","volume":"67","author":"T Bednarczuk","year":"2016","unstructured":"Bednarczuk T, Bolanowski M, Sworczak K, G\u00f3rnicka B, Cieszanowski A, Otto M, Ambroziak U, Pachucki J, Kubicka E, Babi\u0144ska A, Koperski \u0141, Januszewicz A, Prejbisz A, G\u00f3rska M, Jarz\u0105b B, Hubalewska-Dydejczyk A, Glinicki P, Rucha\u0142a M, Kasperlik-Za\u0142uska A (2016) Adrenal incidentaloma in adults-management recommendations by the Polish Society of Endocrinology. Endokrynol Pol 67(2):234\u2013258. https:\/\/doi.org\/10.5603\/EP.a2016.0039","journal-title":"Endokrynol Pol"},{"issue":"1","key":"2154_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.surg.2017.07.030","volume":"163","author":"K Chomsky-Higgins","year":"2018","unstructured":"Chomsky-Higgins K, Seib C, Rochefort H, Gosnell J, Shen WT, Kahn JG, Duh QY, Suh I (2018) Less is more: cost-effectiveness analysis of surveillance strategies for small, nonfunctional, radiographically benign adrenal incidentalomas. Surgery 163(1):197\u2013204. https:\/\/doi.org\/10.1016\/j.surg.2017.07.030","journal-title":"Surgery"},{"issue":"2","key":"2154_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7326\/M18-3630","volume":"171","author":"YS Elhassan","year":"2019","unstructured":"Elhassan YS, Alahdab F, Prete A, Delivanis DA, Khanna A, Prokop L, Murad MH, O\u2019Reilly MW, Arlt W, Bancos I (2019) Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis. Ann Intern Med 171(2):107\u2013116. https:\/\/doi.org\/10.7326\/M18-3630","journal-title":"Ann Intern Med"},{"issue":"1","key":"2154_CR21","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee (2022) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care 45(1):S17\u2013S38. https:\/\/doi.org\/10.2337\/dc22-S002","journal-title":"Diabetes Care"},{"issue":"1","key":"2154_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, ESC Scientific Document Group (2020) 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41(1):111\u2013188. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"issue":"1065","key":"2154_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/postgradmedj-2013-132386","volume":"90","author":"E Davenport","year":"2014","unstructured":"Davenport E, Lang Ping Nam P, Wilson M, Reid A, Aspinall S (2014) Adrenal incidentalomas: management in British district general hospitals. Postgrad Med J 90(1065):365\u2013369. https:\/\/doi.org\/10.1136\/postgradmedj-2013-132386","journal-title":"Postgrad Med J"},{"issue":"5","key":"2154_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2265.2008.03492.x","volume":"70","author":"E Vassilatou","year":"2009","unstructured":"Vassilatou E, Vryonidou A, Michalopoulou S, Manolis J, Caratzas J, Phenekos C, Tzavara I (2009) Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study. Clin Endocrinol (Oxf) 70(5):674\u2013679. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03492.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2154_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1530\/eje.1.02110","volume":"154","author":"B B\u00fclow","year":"2006","unstructured":"B\u00fclow B, Jansson S, Juhlin C, Steen L, Thor\u00e9n M, Wahrenberg H, Valdemarsson S, W\u00e4ngberg B, Ahr\u00e9n B (2006) Adrenal incidentaloma\u2014follow-up results from a swedish prospective study. Eur J Endocrinol 154(3):419\u2013423. https:\/\/doi.org\/10.1530\/eje.1.02110","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2154_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/BF03346546","volume":"33","author":"S Yener","year":"2010","unstructured":"Yener S, Ertilav S, Secil M, Demir T, Akinci B, Kebapcilar L, Comlekci A, Bayraktar F, Yesil S (2010) Prospective evaluation of tumor size and hormonal status in adrenal incidentalomas. J Endocrinol Invest 33(1):32\u201336. https:\/\/doi.org\/10.1007\/BF03346546","journal-title":"J Endocrinol Invest"},{"key":"2154_CR27","doi-asserted-by":"publisher","first-page":"794197","DOI":"10.3389\/fendo.2021.794197","volume":"12","author":"F Ceccato","year":"2021","unstructured":"Ceccato F, Tizianel I, Voltan G, Maggetto G, MeranteBoschin I, Quaia E, Crim\u00ec F, Scaroni C (2021) Attenuation value in adrenal incidentalomas: a longitudinal study. Front Endocrinol (Lausanne) 12:794197. https:\/\/doi.org\/10.3389\/fendo.2021.794197","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2154_CR28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/BF02084835","volume":"139","author":"J Tat\u00e1r","year":"1938","unstructured":"Tat\u00e1r J (1938) Glaukom bei Morbus Cushing. Graefes Arch Ophthal 139:793\u2013800","journal-title":"Graefes Arch Ophthal"},{"issue":"8","key":"2154_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/archopht.1987.01060080062029","volume":"105","author":"B Schwartz","year":"1987","unstructured":"Schwartz B, McCarty G, Rosner B (1987) Increased plasma free cortisol in ocular hypertension and open angle glaucoma. Arch Ophthalmol 105(8):1060\u20131065. https:\/\/doi.org\/10.1001\/archopht.1987.01060080062029","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"2154_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0002-9394(74)90238-4","volume":"78","author":"JS Haas","year":"1974","unstructured":"Haas JS, Nootens RH (1974) Glaucoma secondary to benign adrenal adenoma. Am J Ophthalmol 78(3):497\u2013500. https:\/\/doi.org\/10.1016\/0002-9394(74)90238-4","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"2154_CR31","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1167\/iovs.11-8497","volume":"53","author":"A Jain","year":"2012","unstructured":"Jain A, Wordinger RJ, Yorio T, Clark AF (2012) Spliceosome protein (SRp) regulation of glucocorticoid receptor isoforms and glucocorticoid response in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 53(2):857\u2013866. https:\/\/doi.org\/10.1167\/iovs.11-8497","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"2154_CR32","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00204-018-2187-y","volume":"92","author":"CH Munkboel","year":"2018","unstructured":"Munkboel CH, Baake MLK, Styrishave B (2018) Atorvastatin decreases steroid production in H295R cells and in major endocrine tissues of male rats. Arch Toxicol 92(5):1703\u20131715. https:\/\/doi.org\/10.1007\/s00204-018-2187-y","journal-title":"Arch Toxicol"},{"issue":"10","key":"2154_CR33","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1055\/a-1099-9556","volume":"52","author":"E London","year":"2020","unstructured":"London E, Tatsi C, Soldin SJ, Wassif CA, Backlund P, Ng D, Biesecker LG, Stratakis CA (2020) Acute statin administration reduces levels of steroid hormone precursors. Horm Metab Res 52(10):742\u2013746. https:\/\/doi.org\/10.1055\/a-1099-9556","journal-title":"Horm Metab Res"},{"issue":"4","key":"2154_CR34","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/07435809609043773","volume":"22","author":"M Reincke","year":"1996","unstructured":"Reincke M, Fassnacht M, V\u00e4th S, Mora P, Allolio B (1996) Adrenal incidentalomas: a manifestation of the metabolic syndrome? Endocr Res 22(4):757\u2013761. https:\/\/doi.org\/10.1080\/07435809609043773","journal-title":"Endocr Res"},{"issue":"3","key":"2154_CR35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1365-2265.2010.03928.x","volume":"74","author":"G Muscogiuri","year":"2011","unstructured":"Muscogiuri G, Sorice GP, Prioletta A, Mezza T, Cipolla C, Salomone E, Giaccari A, Pontecorvi A, Della Casa S (2011) The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship? Clin Endocrinol (Oxf) 74(3):300\u20135. https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03928.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2154_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-2265.1998.00437.x","volume":"49","author":"JM Fern\u00e1ndez-Real","year":"1998","unstructured":"Fern\u00e1ndez-Real JM, Engel WR, Sim\u00f3 R, Salinas I, Webb SM (1998) Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma. Clin Endocrinol (Oxf) 49(1):53\u201361. https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00437.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2154_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","volume":"92","author":"KI Avgerinos","year":"2019","unstructured":"Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M (2019) Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism 92:121\u2013135. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.001","journal-title":"Metabolism"},{"issue":"8","key":"2154_CR38","doi-asserted-by":"publisher","first-page":"dgaa270","DOI":"10.1210\/clinem\/dgaa270","volume":"105","author":"G Di Dalmazi","year":"2020","unstructured":"Di Dalmazi G, Vicennati V, Pizzi C, Mosconi C, Tucci L, Balacchi C, Cosentino ER, Paolisso P, Fanelli F, Gambineri A, Pelusi C, Repaci A, Garelli S, Gali\u00e8 N, Borghi C, Golfieri R, Pagotto U (2020) Prevalence and incidence of atrial fibrillation in a large cohort of adrenal incidentalomas: a long-term study. J Clin Endocrinol Metab 105(8):dgaa270. https:\/\/doi.org\/10.1210\/clinem\/dgaa270","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2154_CR39","doi-asserted-by":"publisher","first-page":"656","DOI":"10.5935\/abc.20180188","volume":"111","author":"G Sokmen","year":"2018","unstructured":"Sokmen G, Sahin M, Tuzun D, Sokmen A, Bolat H, Oguz A, Doganer A, Nacar H, Gul K (2018) Assessment of subclinical cardiac alterations and atrial electromechanical delay by tissue doppler echocardiography in patients with nonfunctioning adrenal incidentaloma. Arq Bras Cardiol 111(5):656\u2013663. https:\/\/doi.org\/10.5935\/abc.20180188","journal-title":"Arq Bras Cardiol"},{"key":"2154_CR40","doi-asserted-by":"publisher","first-page":"110488","DOI":"10.1016\/j.mce.2019.110488","volume":"494","author":"MH Park","year":"2019","unstructured":"Park MH, Park SI, Kim JH, Yu J, Lee EH, Seo SR, Jo SH (2019) The acute effects of hydrocortison on cardiac electrocardiography, action potentials, intracellular calcium, and contraction: the role of protein kinase C. Mol Cell Endocrinol 494:110488. https:\/\/doi.org\/10.1016\/j.mce.2019.110488","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2154_CR41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1530\/EJE-17-0986","volume":"178","author":"E Sbardella","year":"2018","unstructured":"Sbardella E, Minnetti M, D\u2019Aluisio D, Rizza L, Di Giorgio MR, Vinci F, Pofi R, Giannetta E, Venneri MA, Vestri A, Morelli S, Lenzi A, Isidori AM (2018) Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas. Eur J Endocrinol 178(5):501\u2013511. https:\/\/doi.org\/10.1530\/EJE-17-0986","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2154_CR42","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218","volume":"8","author":"I Bancos","year":"2020","unstructured":"Bancos I, Taylor AE, Chortis V, Sitch AJ, Jenkinson C, Davidge-Pitts CJ, Lang K, Tsagarakis S, Macech M, Riester A, Deutschbein T, Pupovac ID, Kienitz T, Prete A, Papathomas TG, Gilligan LC, Bancos C, Reimondo G, Haissaguerre M, Marina L, Grytaas MA, Sajwani A, Langton K, Ivison HE, Shackleton CHL, Erickson D, Asia M, Palimeri S, Kondracka A, Spyroglou A, Ronchi CL, Simunov B, Delivanis DA, Sutcliffe RP, Tsirou I, Bednarczuk T, Reincke M, Burger-Stritt S, Feelders RA, Canu L, Haak HR, Eisenhofer G, Dennedy MC, Ueland GA, Ivovic M, Tabarin A, Terzolo M, Quinkler M, Kastelan D, Fassnacht M, Beuschlein F, Ambroziak U, Vassiliadi DA, O\u2019Reilly MW, Young WF Jr, Biehl M, Deeks JJ, Arlt W, ENSATEURINE-ACT Investigators (2020) Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study. Lancet Diabetes Endocrinol 8(9):773\u2013781. https:\/\/doi.org\/10.1016\/S2213-8587(20)30218","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02154-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02154-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02154-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T21:35:20Z","timestamp":1708032920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02154-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["2154"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02154-9","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"assertion":[{"value":"12 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local Ethics Committee (A.O.U. \"Maggiore della Carit\u00e0\"\nNovara) and was in accordance with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Written informed consent was obtained from each patient included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}